Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

ASPO Report

Future Directions for Postdoctoral Training in Cancer Prevention: Insights from a Panel of Experts

David E. Nelson, Jessica Faupel-Badger, Siobhan Phillips, Britni Belcher, Shine Chang, David B. Abrams, Barnett S. Kramer, Mary C. White, Michael O'Malley, Arti P. Varanasi, Carol J. Fabian, Jonathan S. Wiest, Graham A. Colditz, Kara Hall, Peter G. Shields and Jeffrey N. Weitzel
David E. Nelson
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Faupel-Badger
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siobhan Phillips
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Britni Belcher
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shine Chang
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David B. Abrams
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barnett S. Kramer
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary C. White
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael O'Malley
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arti P. Varanasi
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carol J. Fabian
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan S. Wiest
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham A. Colditz
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kara Hall
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter G. Shields
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey N. Weitzel
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-13-1209 Published April 2014
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Table 1.

    Suggested strategies for recruiting people from a variety of disciplines, enhancing curricula, and improving career preparation for postdoctoral cancer prevention fellowship programs

    Broadening disciplinesScientific curriculaCareer preparation
    • Offer undergraduate- or graduate-level summer programs in cancer prevention.

    • Develop specific undergraduate or graduate school cancer prevention tracks or credentialing; this could include experiential learning with cancer prevention scientists.

    • Attend science career events sponsored by professional societies across the spectrum of disciplines that could contribute to cancer prevention research.

    • Hold joint cancer prevention professional meetings with organizations that are not traditionally involved in health (e.g., community planners, engineers, etc.).

    • Directly reach out to professors or students in underrepresented disciplines, and consider creating challenges and asking for ideas/assistance.

    • Develop closer ties with existing university science, technology, engineering, or medicine (STEM) programs.

    • Provide support for coursework or extensive training in selected areas (e.g., epidemiology, biostatistics, cancer biology, behavioral science, etc.).

    • Provide or authorize fellows to attend comprehensive course(s) on the state of the art in cancer prevention.

    • Provide lectures on key topics or themes in cancer prevention (e.g., history, disciplines' contributions, biology, or seminal studies).

    • Provide lectures or other meetings led by established cancer prevention researchers.

    • Develop collaborative research projects on research questions or topics that involve fellows from different disciplines.

    • Develop certification or examination criteria in cancer prevention.

    • Provide short-term opportunities or assignments to different program areas, projects, or types of positions in cancer prevention and control.

    • Directly inform fellows about cancer prevention career options through lectures or group meetings, or through sessions sponsored by professional associations, agencies, or institutions (e.g., AACR, ASPO, or NIH).

    • Convene facilitated individual or small group career planning meetings; consider using preexisting materials (e.g., books not necessarily specific to the sciences).

    • Provide opportunities to conduct cancer prevention research projects or other activities through national, state, or local governmental or nongovernmental partners.

    • Create or enhance a network of alumni from cancer prevention postdoctoral programs.

PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 23 (4)
April 2014
Volume 23, Issue 4
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Future Directions for Postdoctoral Training in Cancer Prevention: Insights from a Panel of Experts
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Future Directions for Postdoctoral Training in Cancer Prevention: Insights from a Panel of Experts
David E. Nelson, Jessica Faupel-Badger, Siobhan Phillips, Britni Belcher, Shine Chang, David B. Abrams, Barnett S. Kramer, Mary C. White, Michael O'Malley, Arti P. Varanasi, Carol J. Fabian, Jonathan S. Wiest, Graham A. Colditz, Kara Hall, Peter G. Shields and Jeffrey N. Weitzel
Cancer Epidemiol Biomarkers Prev April 1 2014 (23) (4) 679-683; DOI: 10.1158/1055-9965.EPI-13-1209

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Future Directions for Postdoctoral Training in Cancer Prevention: Insights from a Panel of Experts
David E. Nelson, Jessica Faupel-Badger, Siobhan Phillips, Britni Belcher, Shine Chang, David B. Abrams, Barnett S. Kramer, Mary C. White, Michael O'Malley, Arti P. Varanasi, Carol J. Fabian, Jonathan S. Wiest, Graham A. Colditz, Kara Hall, Peter G. Shields and Jeffrey N. Weitzel
Cancer Epidemiol Biomarkers Prev April 1 2014 (23) (4) 679-683; DOI: 10.1158/1055-9965.EPI-13-1209
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Future Research Needs
    • Broadening and Expanding Disciplines Involved in Cancer Prevention Research
    • Curriculum
    • Career Preparation
    • Conclusion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Implementation Science in Global Tobacco Control
  • Why Aren't Sexual Orientation/Gender Identity Being Measured?
  • U.S. Dietary Guidelines and Cancer Prevention
Show more ASPO Report
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement